Moderna CEO pushes for second COVID-19 booster shot, but doctors aren't yet convinced it's necessary

During its third-quarter earnings results report, Moderna said commercial booster market sales could be up to $2 billion in the United States in 2022.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.